Immunovant
IMVT
IMVT
94 hedge funds and large institutions have $157M invested in Immunovant in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 31 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
16% less funds holding
Funds holding: 112 → 94 (-18)
21% less capital invested
Capital invested by funds: $197M → $157M (-$40.5M)
54% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 26
Holders
94
Holding in Top 10
1
Calls
$2.51M
Puts
$629K
Top Buyers
| 1 | +$8.7M | |
| 2 | +$2.29M | |
| 3 | +$1.08M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$993K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$912K |
Top Sellers
| 1 | -$15.4M | |
| 2 | -$3.49M | |
| 3 | -$2.53M | |
| 4 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$2.03M |
| 5 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$1.92M |